Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Blake Insomnia Therapeutics, Inc. | bkit_ex311.htm |
| 10-Q - FORM 10-Q - Blake Insomnia Therapeutics, Inc. | bkit_10q.htm |
EXHIBIT 32.1
Section 1350 Certifications
Blake Insomnia Therapeutics, Inc.
Pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsection (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Blake Insomnia Therapeutics, Inc., a Nevada corporation (the "Company"), does hereby certify that:
The Quarterly Report on Form 10-Q for the quarter ended February 28, 2017 (the "Form 10-Q") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: April 14, 2017 | By: | /s/ BIRGER JAN OLSEN | |
|
|
|
BIRGER JAN OLSEN | |
| Principal Executive Officer | |||
| and Principal Financial Officer |